Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The process of allergen recognition by the immune system involves the initial detection of exogenous proteins—known as allergens—by antigen-presenting cells (especially dendritic cells and macrophages, as well as epithelial cells) through a diverse array of pattern recognition receptors, including Toll-like receptors, C-type lectin receptors, and the high-affinity IgE receptor FcεRI[1][3][2]. These receptors initiate signaling cascades that lead to the internalization and processing of allergens, presentation to T helper cells (typically CD4+ Th2 cells via MHC class II molecules), and subsequent secretion of cytokines that drive an IgE-mediated allergic inflammatory response[1][2][3][4]. This pathway is critical in the pathogenesis of allergic diseases and underlies the molecular and cellular basis for disorders such as asthma, rhinoconjunctivitis, atopic dermatitis, and systemic allergic reactions[1][3][2][4]. Importantly, this entry refers to a class of biological processes rather than a unique molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allergen recognition by immune system.